Biopharma eyes $100M for crypto treasury to back cancer treatment
Propanc Biopharma said it will build a crypto treasury after securing up to $100 million from Hexstone Capital to further its potential cancer treatment and reignite investor interest.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Propanc Biopharma said it will build a crypto treasury after securing up to $100 million from Hexstone Capital to further its potential cancer treatment and reignite investor interest.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
SEC's Atkins backs Clarity Act but says agency will keep pushing crypto rules without it
The SEC chair said crypto issuance, transfer agent modernization and custody will form the backbone of the agency’s regulatory pus...
Strategy Buys Back $139 Million of STRC, Bitcoin Stack Frozen for Second Week
The Bitcoin treasury firm slowed its preferred-stock buyback from last week's $176 million pace and left its 845,050 BTC untouched...
Strategy Buys Back Stock, Skips Bitcoin Purchase
Bitcoin Magazine Strategy Buys Back Stock, Skips Bitcoin Purchase Bitcoin treasury Strategy held off buying bitcoin again last wee...
DeFi Development Corp expands Solana treasury to 2.39 million SOL, sets up $300 million CHAD ATM
The Solana treasury company established a $300 million at-the-market offering for its CHAD perpetual preferred stock.
Another public company has abandoned its Bitcoin treasury after selling the last 764 BTC
KULR Technology Group has sold its remaining Bitcoin, completing a retreat from a treasury strategy it began unwinding in August....
Bitcoin ETFs just lost $463 million as the Fed puts BTC at risk of losing $75,000
US spot Bitcoin exchange-traded funds (ETFs) posted $462.7 million in weekly outflows, ending a three-week stretch of heavy invest...